VentriPoint Free Cash Flow Yield vs Invested Capital Analysis

VPT Stock  CAD 0.10  0.01  9.09%   
VentriPoint Diagnostics financial indicator trend analysis is much more than just breaking down VentriPoint Diagnostics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether VentriPoint Diagnostics is a good investment. Please check the relationship between VentriPoint Diagnostics Free Cash Flow Yield and its Invested Capital accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Free Cash Flow Yield vs Invested Capital

Free Cash Flow Yield vs Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of VentriPoint Diagnostics Free Cash Flow Yield account and Invested Capital. At this time, the significance of the direction appears to have weak relationship.
The correlation between VentriPoint Diagnostics' Free Cash Flow Yield and Invested Capital is 0.38. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Invested Capital in the same time period over historical financial statements of VentriPoint Diagnostics, assuming nothing else is changed. The correlation between historical values of VentriPoint Diagnostics' Free Cash Flow Yield and Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of VentriPoint Diagnostics are associated (or correlated) with its Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Invested Capital has no effect on the direction of Free Cash Flow Yield i.e., VentriPoint Diagnostics' Free Cash Flow Yield and Invested Capital go up and down completely randomly.

Correlation Coefficient

0.38
Relationship DirectionPositive 
Relationship StrengthVery Weak

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Invested Capital

Invested capital represents the total cash investment that shareholders and debt holders have contributed to VentriPoint Diagnostics. There are two different methods for calculating VentriPoint Diagnostics invested capital: operating approach and financing approach. Understanding VentriPoint Diagnostics invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.
Most indicators from VentriPoint Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into VentriPoint Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, VentriPoint Diagnostics' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value is likely to climb to about 42.9 M in 2025, whereas Selling General Administrative is likely to drop slightly above 1.7 M in 2025.
 2022 2023 2024 2025 (projected)
Depreciation And Amortization50.9K66.7K76.7K45.9K
Income Tax Expense136.1K3.03.453.28

VentriPoint Diagnostics fundamental ratios Correlations

-0.310.92-0.97-0.390.21.01.00.420.490.34-0.311.00.0-0.160.20.150.370.26-0.46-0.29-0.470.29-0.13-0.46-0.22
-0.31-0.620.440.180.2-0.33-0.33-0.13-0.430.20.93-0.30.060.32-0.39-0.37-0.42-0.280.550.630.430.1-0.30.050.28
0.92-0.62-0.97-0.390.050.930.930.390.570.16-0.650.92-0.07-0.380.30.260.460.33-0.66-0.43-0.520.190.07-0.44-0.21
-0.970.44-0.970.38-0.1-0.97-0.97-0.32-0.49-0.190.5-0.970.00.37-0.17-0.13-0.41-0.340.590.290.48-0.27-0.060.430.16
-0.390.18-0.390.38-0.73-0.36-0.36-0.68-0.85-0.280.17-0.370.350.06-0.56-0.51-0.88-0.790.580.630.83-0.560.230.760.11
0.20.20.05-0.1-0.730.160.160.40.420.410.260.18-0.090.250.150.080.570.59-0.19-0.54-0.560.61-0.44-0.55-0.07
1.0-0.330.93-0.97-0.360.161.00.350.450.28-0.341.00.02-0.180.150.10.350.25-0.46-0.29-0.450.26-0.09-0.41-0.24
1.0-0.330.93-0.97-0.360.161.00.350.450.28-0.341.00.02-0.180.150.10.360.25-0.46-0.29-0.450.26-0.09-0.42-0.24
0.42-0.130.39-0.32-0.680.40.350.350.830.62-0.060.39-0.550.090.80.770.580.34-0.47-0.36-0.610.36-0.49-0.74-0.21
0.49-0.430.57-0.49-0.850.420.450.450.830.34-0.380.46-0.62-0.090.820.780.880.63-0.71-0.58-0.870.39-0.24-0.74-0.25
0.340.20.16-0.19-0.280.410.280.280.620.340.290.33-0.130.340.40.370.140.01-0.04-0.09-0.310.55-0.44-0.42-0.28
-0.310.93-0.650.50.170.26-0.34-0.34-0.06-0.380.29-0.310.040.63-0.28-0.28-0.36-0.320.680.480.330.09-0.460.130.08
1.0-0.30.92-0.97-0.370.181.01.00.390.460.33-0.310.01-0.170.170.120.350.24-0.45-0.28-0.450.28-0.12-0.44-0.22
0.00.06-0.070.00.35-0.090.020.02-0.55-0.62-0.130.040.010.02-0.61-0.61-0.47-0.10.420.120.41-0.020.080.420.13
-0.160.32-0.380.370.060.25-0.18-0.180.09-0.090.340.63-0.170.020.080.02-0.06-0.250.63-0.09-0.050.02-0.590.26-0.41
0.2-0.390.3-0.17-0.560.150.150.150.80.820.4-0.280.17-0.610.080.990.630.32-0.49-0.37-0.650.23-0.22-0.51-0.25
0.15-0.370.26-0.13-0.510.080.10.10.770.780.37-0.280.12-0.610.020.990.580.3-0.48-0.3-0.590.22-0.17-0.49-0.18
0.37-0.420.46-0.41-0.880.570.350.360.580.880.14-0.360.35-0.47-0.060.630.580.84-0.63-0.66-0.910.57-0.11-0.51-0.18
0.26-0.280.33-0.34-0.790.590.250.250.340.630.01-0.320.24-0.1-0.250.320.30.84-0.52-0.53-0.710.65-0.01-0.40.16
-0.460.55-0.660.590.58-0.19-0.46-0.46-0.47-0.71-0.040.68-0.450.420.63-0.49-0.48-0.63-0.520.40.66-0.24-0.210.63-0.06
-0.290.63-0.430.290.63-0.54-0.29-0.29-0.36-0.58-0.090.48-0.280.12-0.09-0.37-0.3-0.66-0.530.40.65-0.240.110.360.28
-0.470.43-0.520.480.83-0.56-0.45-0.45-0.61-0.87-0.310.33-0.450.41-0.05-0.65-0.59-0.91-0.710.660.65-0.530.170.550.23
0.290.10.19-0.27-0.560.610.260.260.360.390.550.090.28-0.020.020.230.220.570.65-0.24-0.24-0.53-0.02-0.240.12
-0.13-0.30.07-0.060.23-0.44-0.09-0.09-0.49-0.24-0.44-0.46-0.120.08-0.59-0.22-0.17-0.11-0.01-0.210.110.17-0.020.330.16
-0.460.05-0.440.430.76-0.55-0.41-0.42-0.74-0.74-0.420.13-0.440.420.26-0.51-0.49-0.51-0.40.630.360.55-0.240.330.04
-0.220.28-0.210.160.11-0.07-0.24-0.24-0.21-0.25-0.280.08-0.220.13-0.41-0.25-0.18-0.180.16-0.060.280.230.120.160.04
Click cells to compare fundamentals

VentriPoint Diagnostics Account Relationship Matchups

VentriPoint Diagnostics fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets801.6K9.5M6.0M1.9M2.2M2.0M
Total Current Liabilities1.8M1.1M1.1M1.4M1.6M2.1M
Total Stockholder Equity(2.3M)8.3M4.6M189.7K218.2K229.1K
Net Debt843.8K(9.1M)(4.7M)(1.0M)(918.0K)(872.1K)
Retained Earnings(39.9M)(43.7M)(48.6M)(53.5M)(48.1M)(45.7M)
Accounts Payable1.0M988.6K842.0K856.2K984.7K792.2K
Cash526.0K9.3M5.2M1.3M1.5M1.5M
Cash And Short Term Investments526.0K9.3M5.2M1.3M1.5M1.5M
Net Receivables165.3K197.5K374.2K285.5K328.3K344.7K
Common Stock Shares Outstanding74.5M136.1M156.0M156.8M180.3M189.4M
Liabilities And Stockholders Equity801.6K9.5M6.0M1.9M2.2M2.0M
Other Stockholder Equity6.4M9.8M10.4M10.9M12.6M7.5M
Total Liab3.2M1.2M1.4M1.7M1.9M2.6M
Total Current Assets714.5K9.5M5.7M1.6M1.9M1.9M
Non Current Liabilities Total1.3M125.4K367.4K297.0K267.3K468.6K
Property Plant And Equipment Net87.1K42.5K313.3K246.6K283.6K297.8K
Non Current Assets Total87.1K42.5K313.3K246.6K283.6K297.8K
Short Long Term Debt Total1.4M160.0K459.1K274.4K246.9K234.6K
Other Current Liab500.062.3K122.1K453.6K408.3K753.2K
Short Term Debt42.8K34.6K91.6K55.0K49.5K47.0K
Long Term Debt1.3M125.4K93.1K77.6K69.9K66.4K
Other Current Assets23.1K35.9K103.5K56.9K51.2K73.8K
Common Stock29.5M31.0M42.2M42.7M49.1M28.8M
Net Invested Capital(1.1M)8.5M4.7M327.8K376.9K358.1K
Net Working Capital(1.1M)8.4M4.6M240.1K276.1K262.3K
Capital Stock29.5M31.0M42.2M42.7M49.1M39.7M
Capital Lease Obligations77.3K34.6K316.2K274.4K315.5K179.2K
Property Plant And Equipment Gross225.7K194.6K474.5K246.6K283.6K307.7K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for VentriPoint Stock Analysis

When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.